Boston Scientific Corp (BSX)

Debt-to-assets ratio

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Long-term debt	US$ in thousands	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Total assets	US$ in thousands	35,136,000	34,043,000	33,601,000	32,892,000	32,469,000	31,947,000	32,189,000	32,337,000	32,229,000	31,877,000	31,168,000	30,900,000	30,777,000	30,845,000	30,823,000	30,113,000	30,565,000	26,756,000	24,309,000	23,802,000
Debt-to-assets ratio		0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00

December 31, 2023 calculation

Debt-to-assets ratio = Long-term debt ÷ Total assets
= $—K ÷ $35,136,000K
= 0.00

Boston Scientific Corp.'s debt-to-assets ratio has shown a consistent trend over the past eight quarters. The ratio has ranged from 0.26 to 0.29 during this period, indicating that the company finances a significant portion of its assets through debt.

The decreasing trend in the debt-to-assets ratio from Q1 2022 to Q4 2023 suggests that the company may be effectively managing its debt levels relative to its asset base. However, the ratio still remains relatively high, indicating that Boston Scientific Corp. relies on debt to fund a considerable part of its operations and investments.

It is important for stakeholders to monitor this ratio closely to ensure that the company's debt levels are sustainable and that it does not become overleveraged. Additionally, a high debt-to-assets ratio may imply greater financial risk for the company, as it could lead to higher interest payments and potential liquidity challenges in the future.